from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2246/kasB

LFCtreatmentdescriptionclass of inhibitor

-2.084

Amikacinug/mL Amikacintranslation

-1.725

Cap5-10ug/mL Capreomycintranslation

-1.541

Rox10-50 ug/mL Roxithromycintranslation

-0.913

SM2-5 ug/mL Streptomycintranslation

-1.779

Tet5-10 ug/mL Tetracyclinetranslation

-1.070

Rif0.2-5ug/mL Rifampicintranscription

-0.304

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.072

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.351

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.291

CPZ10-50 ug/mL Chlorpromazinerespiration

0.568

Clofazimine10-13 ug/mL Clofaziminerespiration

0.421

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.795

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.323

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.375

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.201

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.787

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.815

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.184

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.982

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.314

KCN5-20 ug/mL Potassium cyaniderespiration

-0.057

NaN30.2-2 mM Sodium aziderespiration

-0.306

Nigericin50 uM Nigericinrespiration

-1.214

TRC10-150 ug/mL Triclosanrespiration

-0.301

TRZ10-25 ug/mL Thioridazinerespiration

-0.805

Valinomycin0.5-10 uM Valinomycinrespiration

0.153

ZnSO42 mM ZnSO4respiration

-0.997

menadione6-10 ug/mL Menadionerespiration

-0.220

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.499

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.450

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.602

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.225

NRP_1Non-replicating persistence stage 1dosRassociated

0.652

Amp0.2mg/mL AmpicillincellWall

0.364

Cephalexin20-100 ug/mL CephalexincellWall

0.983

Cerulenin0.32-5 ug/mL CerulenincellWall

0.117

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.496

EMB10-20 ug/mL EthambutolcellWall

2.894

Eta12-40 ug/mL EthionamidecellWall

3.128

INH0.2-0.4 ug/mL IsoniazidcellWall

2.729

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.412

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.476

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.398

BZA0.12 mg/mL BenzamidearomaticAmides

0.189

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.445

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.362

H2O24 mM hydrogen peroxideDNAdamaging

0.272

Levo10 ug/mL LevofloxacinDNAdamaging

0.793

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.633

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.465

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.579

UVUV-irradiationDNAdamaging

0.071

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.214

Antimycin12.5-50 ug/mL Antimycin A?

0.443

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.435

PA_110-50 ug/mL Antitubercular compound PA-1?

0.299

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.317

PA8240.2-2 ug/mL PA-824?

-0.333

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.064

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.291

Verapamil50 uM Verapamil?

0.454

mercaptoethanol2 mM 2-Mercaptoethanol?

0.167

methoxatin10-20 ug/mL Methoxatin?